The global immunotherapy drugs market size was valued at USD 268.6 billion in 2024 and is expected to grow at a CAGR of 13.6% from 2025 to 2030. This market is primarily driven by the rising incidence of chronic diseases globally. According to the International Diabetes Federation (IDF),... Read More »
December 2024The global spinal muscular atrophy treatment market size was estimated at USD 4.40 billion in 2024 and is anticipated to grow at a CAGR of 18.0% from 2025 to 2030. The increasing advancements in gene therapy have played a pivotal role in revolutionizing the treatment of spinal muscular a... Read More »
December 2024The global uveitis treatment market size was valued at USD 2.23 billion in 2023 and is projected to grow at a CAGR of 9.1% from 2024 to 2030. The growth is due to rising prevalence of uveitis, increased awareness and early diagnosis. The growing R&D activities in the field of ophthal... Read More »
December 2024The global pneumonia therapeutics market size was valued at USD 2.28 billion in 2023 and is projected to grow at a CAGR of 9.4% from 2024 to 2030. The growing incidence of pneumococcal disease is a high impact rendering driver. Over the years, there has been a significant upsurge in the ... Read More »
December 2024The global dermatological drugs market size was valued at USD 23.9 billion in 2024 and is anticipated to grow at a CAGR of 10.1% from 2025 to 2030. Key factors driving the market include skin parasites, fungi, bacteria trapped in pores and hair follicles, fluid retention, dehydration pre... Read More »
December 2024The global rosacea treatment market was estimated at USD 2.08 billion in 2024 and is projected to grow at a CAGR of 7.1% from 2025 to 2030. The increasing prevalence of rosacea is largely due to urbanization, environmental changes, and lifestyle shifts, particularly among fair-skinned in... Read More »
December 2024The global paroxysmal nocturnal hemoglobinuria treatment market size was estimated at USD 5.75 billion in 2024 and is projected to grow at a CAGR of 9.6% from 2025 to 2030. The increasing prevalence of paroxysmal nocturnal hemoglobinuria (PNH) is driven by better awareness and improved d... Read More »
December 2024The global stomach cancer treatment market size was estimated at USD 5.37 billion in 2024 and is projected to grow at a CAGR of 12.5% from 2025 to 2030. The World Cancer Research Fund estimated the incidence of over 1.1 million new cases in 2023, showing an alarming rise in the incidence... Read More »
December 2024The global synthetic small molecule API market size was valued at USD 185.2 billion in 2024 and is projected to grow at a CAGR of 5.6% from 2025 to 2030. The increasing demand for small molecule APIs and the growing trend of outsourcing production are major factors driving market growth.... Read More »
December 2024The global vaccine adjuvants market size was estimated at USD 3.81 billion in 2024 and is projected to grow at a CAGR of 4.3% from 2025 to 2030. The market is driven by the increasing demand for effective vaccines to combat emerging and re-emerging infectious diseases, as well as the ris... Read More »
December 2024The global CBD nutraceuticals market size was valued at USD 10.46 billion in 2024 and is projected to grow at a CAGR of 12.6% from 2025 to 2030. Some of the key growth driving factors for this industry are the increasing prevalence of chronic health disorders, growing consumer awareness ... Read More »
December 2024The global blockbuster oncology brands market size was valued at USD 40.80 billion in 2023 and is projected to grow at a CAGR of 8.0% from 2024 to 2030. The increasing incidence of various cancer types across different age demographics, advancements in oncology research, and the emergenc... Read More »
December 2024The global small molecule API market size was valued at USD 214.2 billion in 2024 and is projected to grow at a CAGR of 5.6% from 2025 to 2030. The rising prevalence of chronic diseases worldwide, increasing demand for small molecule drugs, and increasing emphasis on outsourcing and cont... Read More »
December 2024The global neuroendocrine tumor treatment market was estimated at USD 2.66 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030, primarily driven by the increasing prevalence of neuroendocrine tumors. As awareness of neuroendocrine tumors rises, more individuals a... Read More »
December 2024The global topical drugs market size was estimated at USD 190.5 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. The market growth is increasingly influenced by the rising prevalence of skin conditions and chronic diseases globally. According to the American ... Read More »
December 2024The global myeloproliferative disorders drugs market size was estimated at USD 11.34 billion in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2030. The increasing prevalence of myeloproliferative disorders, particularly among older adults, is a major contributor to market ... Read More »
December 2024The global gastroesophageal reflux disease therapeutics market size was estimated at USD 5.11 billion in 2024 and is projected to grow at a CAGR of 2.0% from 2025 to 2030. Lifestyle changes, including urbanization and dietary habits, further contribute to the rising prevalence of GERD.... Read More »
December 2024The global gabapentin market size was estimated at USD 2.25 billion in 2024 and is projected to grow at a CAGR of 5.2% from 2025 to 2030. According to the American Academy of Neurology, neuropathic pain prevalence stood at an estimated 9.2% in the general population, escalating to nearly... Read More »
December 2024The global post-traumatic stress disorder treatment market size was estimated at USD 2.24 billion in 2024 and is projected to grow at a CAGR of 4.08% from 2025 to 2030. The increasing prevalence of PTSD, driven by traumatic events like natural disasters, terrorist attacks, and armed conf... Read More »
December 2024The global insulin market size was estimated at USD 19.45 billion in 2024 and is projected to grow at a CAGR of 3.7% from 2025 to 2030. The increasing prevalence of diabetes, particularly Type 2, propels the demand for products. Advances in formulations, such as rapid-acting and long-act... Read More »
December 2024